Free weekly newsletter
Get the free weekly contract digest
The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
Merck Sharp & Dohme (MSD) makes first investment in healthtech startup in Asia Pacific with HD partnership
Feb 13, 2025•over 1 year ago
Contract Type
partnership
Description
US pharma giant Merck Sharp & Dohme (MSD) has backed the Thailand-based healthcare startup, HD, with a $7.8 million equity funding to enhance its marketplace and further invest in its AI technology. HD’s marketplace has over 30,000 stock-keeping units (SKUs) from more than 2,500 hospitals and clinics, and a handful of pharmaceutical partners, with 400,000 paying customers across Thailand and Indonesia.
Related People
Suggested for you
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months